Cresco Labs Inc.

Equities

CL

CA22587M1068

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:59:58 2024-03-27 pm EDT 5-day change 1st Jan Change
3.05 CAD 0.00% Intraday chart for Cresco Labs Inc. +9.32% +70.39%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cresco Labs Swings to Profit in Q4, Revenue Drops; Up 10.4% MT
Cresco Labs Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Cresco Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cresco Labs Inc. Provides Revenue Guidance for the First Quarter of 2024 CI
Transcript : Cresco Labs Inc., Q4 2023 Earnings Call, Mar 13, 2024
Cresco Labs Swings to Profit in Q4, Revenue Drops MT
Cresco Labs Brief: Fourth quarter revenue of US$188 million; net income of $5 million. MT
Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store CI
Cresco Labs Inc. Promotes Greg Butler to the Position of President CI
Cresco Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Cresco Labs Inc., Q3 2023 Earnings Call, Nov 15, 2023
Earnings Flash (CL) CRESCO LABS Posts Q3 Revenue $190.6M MT
Cresco Labs Unlocking US$32 Million in Non-Dilutive Capital MT
The Mint Cannabis completed the acquisition of Encanto Green Cross Dispensary, LLC from Cresco Labs Inc. (CNSX:CL) for $6.5 million. CI
Cresco Labs Inc. Launches Good News Brand in Pennsylvania with New Sweet Troches CI
Cresco Labs Inc. Expands Sunnyside in Central Pennsylvania with New Store in Altoona CI
SAFER Banking Act Passes Banking Committee, Sent to the Floor, Notes Wedbush MT
Cresco Labs Launches New Brands in Florida; Down 6.2% MT
Cresco Labs Launches New Brands in Florida MT
Cresco Labs Expands Florida Brand Portfolio with Launch of Floracal and Cresco Live Rosin and Flower Products CI
Piper Sandler on US Opportunities For Cannabis Companies MT
Cresco Labs Inc. Opens 33Rd Florida Sunnyside in Jacksonville, 70Th Store Nationwide CI
Piper Sandler On Cresco Labs; Citing "Impressive Margin Momentum" MT
Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023 CI
Transcript : Cresco Labs Inc., Q2 2023 Earnings Call, Aug 16, 2023
Chart Cresco Labs Inc.
More charts
Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy’s offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2.244 USD
Average target price
3.994 USD
Spread / Average Target
+77.95%
Consensus
  1. Stock
  2. Equities
  3. Stock Cresco Labs Inc. - Canadian Securities Exchange
  4. News Cresco Labs Inc.
  5. Piper Sandler Keeps Overweight, US$14 TP on Cresco Labs After Q4, Columbia Care Deal